Edgewise Therapeutics, Inc. (EWTX) › Weighted Average Diluted SharesEdgewise Therapeutics, Inc. (EWTX) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2020-12-31: 739.0K2021-12-31: 37.53M2022-12-31: 53.59M2023-12-31: 63.72M2024-12-31: 92.41M2025-12-31: 102.93M102.93M2020-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-31102.93M+11.4%2026-02-26From 2025-01-012024-12-3192.41M+45.0%2026-02-26From 2024-01-012023-12-3163.72M+18.9%2026-02-26From 2023-01-012022-12-3153.59M+42.8%2024-02-22From 2022-01-012021-12-3137.53M+4978.0%2023-02-23From 2021-01-012020-12-31739.0K—2022-02-24From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)